icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020
Back grey_arrow_rt.gif
 
 
 
Progression of the FIB-4 Index among
Patients with Chronic HCV Infection

 
 
  AASLD 2020 Nov 11-16
Reported by Jules Levin
 
Lisette A.P. Krassenburg1,2, RaoelMaan1, Amy Puenpatom3, Nicole Erler4, Christoph Welsch5, Stijn van Hees6, Orlando Cerrhoci2, Johannes Vermehren5, Robert J. de Knegt1, Bettina E. Hansen2,7 , Stefan Zeuzem5, Thomas Vanwolleghem6, Harry L.A. Janssen2, Robert A. de Man1, Jordan J. Feld2, Adriaan J. van der Meer1
1. Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands; 2. Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto,Canada; 3. Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USA;
4. Department of Biostatistics, Erasmus MC University Medical Center, Rotterdam, the Netherlands; 5. MedizinischeKlinik1, Klinikumder Johann Wolfgang Goethe-Universitšt, Frankfurt amMain, Germany; 6. Departmentof GastroenterologyandHepatology, University HospitalAntwerp, Antwerp, Belgium;
7. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.

1130201

1130202

1130203

1130204

1130205

1130206

1130207